PROteolysis‐Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives
PROteolysis‐Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives
About this item
Full title
Author / Creator
Publisher
China: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
China: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Leukemia is a heterogeneous group of life‐threatening malignant disorders of the hematopoietic system. Immunotherapy, radiotherapy, stem cell transplantation, targeted therapy, and chemotherapy are among the approved leukemia treatments. Unfortunately, therapeutic resistance, side effects, relapses, and long‐term sequelae occur in a significant pro...
Alternative Titles
Full title
PROteolysis‐Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_bf8c0c69d4d841d6a744bc6d0947a707
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bf8c0c69d4d841d6a744bc6d0947a707
Other Identifiers
ISSN
2688-2663
E-ISSN
2688-2663
DOI
10.1002/mco2.575
